Clinical Trials Browser

Phase 1 × Neurologic Manifestations × Irinotecan × Clear all

NCT00762255 2013-07-25

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Phase 1 Completed

Glioblastoma, Neurologic Manifestations

NCT00251797 2010-01-07

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Phase 1 Completed

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms